Cardiovascular revascularization medicine : including molecular interventions · 2012
Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® drug-eluting peripheral stent.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dvir Danny, Torguson Rebecca, Waksman Ron
Аннотация
Zilver® PTX® (Cook Medical, Bloomington, IN) is a self-expanding nitinol drug-eluting stent with a polymer-free paclitaxel coating on its outer surface. The stent aims to provide improved treatment for patients with symptomatic peripheral arterial disease in the above-the-knee femoropopliteal arteries. On October 13, 2011, the Food and Drug Administration's (FDA) Circulatory System Devices Panel reviewed the Zilver PTX premarket approval application. This summary aims to describe the discussions and recommendations made during the meeting. Based on the Panel's recommendations, it is anticipated that the device will be approved by the FDA.
Предметные рубрики MeSH
Advisory CommitteesAlloysCardiovascular AgentsCoated Materials, BiocompatibleConstriction, PathologicDevice ApprovalDrug-Eluting StentsEndovascular ProceduresEvidence-Based MedicineFemoral ArteryHumansPaclitaxelPeripheral Arterial DiseasePopliteal ArteryProsthesis DesignRandomized Controlled Trials as TopicRegistriesTreatment OutcomeUnited StatesUnited States Food and Drug Administration